Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows

v3.21.2
Condensed Consolidated Statement of Cash Flows
 6 Months Ended
Jun. 30, 2021
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (5,829,716)
Change in fair value of derivative warrant liabilities 3,753,970
Financing costs - derivative warrant liabilities 1,111,480
Unrealized gain on investments held in Trust Account (43,775)
Changes in operating assets and liabilities:  
Prepaid expenses (1,318,225)
Accounts payable 27,964
Accrued expenses 53,396
Due to related party 497,675
Net cash used in operating activities (1,747,231)
Cash Flows from Investing Activities:  
Cash deposited in Trust Account (977,500,000)
Net cash used in investing activities (977,500,000)
Cash Flows from Financing Activities:  
Repayment of note payable to related party (295,179)
Proceeds received from initial public offering, gross 977,500,000
Proceeds received from private placement 22,250,000
Offering costs paid (19,706,097)
Net cash provided by financing activities 979,748,724
Net increase in cash 501,493
Cash - beginning of the period 0
Cash - end of the period 501,493
Supplemental disclosure of noncash investing and financing activities:  
Offering costs included in accrued expenses 236,816
Offering costs paid by related party under promissory note 295,179
Deferred legal fees 18,182
Deferred underwriting commissions 34,212,500
Initial value of Class A ordinary shares subject to possible redemption 905,037,840
Change in value of Class A ordinary shares subject to possible redemption $ (1,056,480)